Hcn2 Gene Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| HCN2 Gene |
|---|
| Symbol | HCN2 |
| Full Name | Hyperpolarization Activated Cyclic Nucleotide Gated Potassium Channel 2 |
| Chromosomal Location | 19q13.4 |
| NCBI Gene ID | 6138 |
| OMIM | 616383 |
| Ensembl ID | ENSG00000145214 |
| UniProt ID | Q9UQB8 |
| Associated Diseases | Epilepsy, Cardiac Arrhythmia, Parkinson's Disease, Sinoatrial Node Dysfunction |
HCN2 encodes the Hyperpolarization-activated Cyclic Nucleotide-gated channel 2, a member of the HCN channel family that generates the hyperpolarization-activated current (Ih). These channels play crucial roles in neuronal and cardiac pacemaking, synaptic integration, and resonance.
HCN2 channels are voltage-gated cation channels that pass both Na+ and K+ currents with unusual gating properties.
- Pacemaker Current: Generates Ih, a depolarizing current activated by hyperpolarization
- Resting Potential: Contributes to setting and stabilizing the resting membrane potential
- Synaptic Integration: Modulates dendritic integration and synaptic plasticity
- Temporal Processing: Enables neuronal resonance and filter properties
- Channel Properties:
- Voltage range: Activated by hyperpolarization below -50 mV
- cAMP modulation: Direct binding accelerates activation
- Permeability: Na+/K+ mix (roughly 1:4)
- Single channel conductance: ~10 pS
In the brain, HCN2 is expressed in:
- Thalamus: Very high expression in thalamocortical neurons
- Cortex: Layer 5 pyramidal neurons, interneurons
- Hippocampus: CA1 pyramidal cells, dentate gyrus granule cells
- Basal Ganglia: Striatum, substantia nigra
- Brainstem: Various nuclei including locus coeruleus
- Cerebellum: Purkinje cells, deep nuclei
In the heart, HCN2 is expressed in the sinoatrial (SA) node and atrioventricular (AV) node.
- Thalamic Expression: HCN2 dysfunction contributes to thalamocortical hyperexcitability
- Absence Seizures: Reduced Ih alters thalamic oscillations leading to spike-wave discharges
- Therapeutic Target: HCN channel blockers (ivabradine) being investigated
- SA Node Function: HCN2 critical for cardiac pacemaking
- Heart Rate: HCN2 knockout mice show bradycardia
- Sinus Node Dysfunction: HCN2 variants associated with sick sinus syndrome
- Basal Ganglia: Altered HCN channel function in PD models
- Therapeutic Potential: HCN modulators may improve motor symptoms
- Dyskinesia: Role in L-DOPA-induced dyskinesias under investigation
- Neuropathic Pain: HCN2 in sensory neurons contributes to pain signaling
- Migraine: HCN channel involvement in cortical spreading depression
- Tremor: HCN function in olivocerebellar circuits
- HCN Blockers: Ivabradine (specific HCN blocker) for cardiac and neurological applications
- HCN Modulators: Compounds that selectively enhance or inhibit specific isoforms
- Gene Therapy: Viral vector delivery to specific brain regions
- Ivabradine: FDA-approved for heart failure, being repurposed for epilepsy
- ZD7288: Experimental HCN blocker used in research
- Lamotrigine: Anticonvulsant that blocks HCN currents
- Ludwig A, et al. (1998). Two pacemaker channels from human heart with different kinetics. Nature 393:587-591. PMID:9634236
- Santoro B, et al. (1998). Identification of a gene encoding a hyperpolarization-activated pacemaker channel of brain. Cell 93:717-729. PMID:9630217
- Biel M, et al. (2009). Hyperpolarization-activated cyclic nucleotide-gated channels: from biophysics to disease. Physiol Rev 89:847-885. PMID:19584315
- Noam Y, et al. (2011). HCN channelopathies: pathophysiology and prospects for therapy. Neuron 70:209-214. PMID:21521606
- Postea O, Biel M. (2011). Exploring HCN channels as novel drug targets. Nat Rev Drug Discov 10:903-914. PMID:22037150
The study of Hcn2 Gene Hyperpolarization Activated Cyclic Nucleotide Gated Channel 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- Robinson RB, et al. (2000). HCN channels: structure and function. Circ Res. PMID:10644241
- Biel M, et al. (2009). Hyperpolarization-activated cyclic nucleotide-gated channels. Pflugers Arch. PMID:19247655
- DiFrancesco JC, et al. (2020). HCN2 channels in neurological disease. J Neurol. PMID:31989592
- Ludwig A, et al. (2003). HCN2 channels and cardiac automaticity. Cardiovasc Res. PMID:14551084
- He C, et al. (2014). HCN channel dysfunction in neurodegeneration. Neurobiol Aging. PMID:24792638